Surgery
Volume 131, Issue 6 , Pages 595-600, June 2002

Ubiquitin proteasome inhibition and cancer therapy☆

Worcester and Boston, Mass

From the Departments of Surgery, University of Massachusetts Medical School, Worcester, and Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Mass

Accepted 18 November 2001.

Abstract 

Surgery 2002;131:595-600.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ Reprint requests: Mark P. Callery, MD, FACS, Division of General Surgery, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215.

PII: S0039-6060(02)00002-8

doi:10.1067/msy.2002.121890

Surgery
Volume 131, Issue 6 , Pages 595-600, June 2002

Article Tools

* Image Usage & Resolution